Skip to main content
First-line ibrutinib an effective treatment for patients with CLL carrying TP53 aberrations
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First-line ibrutinib an effective treatment for patients with CLL carrying TP53 aberrations
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Antineoplastic Drug
0
0.87
Biologic Therapy
0
0.85
Prognosis
0
0.75
Monoclonal Antibody
0
0.71
Leukemia
0
0.61
Cancer
0
0.24
Residual Disease
0
0.24
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.85
Edit Tags